Moderna
MRNA
#705
Rank
NZ$45.28 B
Marketcap
$117.82
Share price
-0.75%
Change (1 day)
-36.04%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Market capitalization of Moderna (MRNA)

Market cap: NZ$45.28 Billion

As of September 2024 Moderna has a market cap of NZ$45.28 Billion. This makes Moderna the world's 705th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Moderna from 2018 to 2024

End of year Market Cap

Year Market cap Change
2024NZ$45.28 B-24.47%
2023NZ$59.95 B-44.83%
2022NZ$108.68 B-27.72%
2021NZ$150.36 B161.59%
2020NZ$57.48 B489.04%
2019NZ$9.75 B30.43%
2018NZ$7.48 B

End of Day market cap according to different sources

On Sep 6th, 2024 the market cap of Moderna was reported to be:

NZ$45.28 Billion
by Yahoo Finance info icon info icon
NZ$45.28 Billion
by CompaniesMarketCap info icon info icon
NZ$45.28 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$0.16 B-99.63%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$482.81 B 966.08%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.34 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$51.20 B 13.07%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$383.05 B 745.81%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$4.46 B-90.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$639.60 B 1,312.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.81 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA